🇺🇸 FDA
Pipeline program

Alogliptin and metformin

SYR-322-MET-008

Phase 3 small_molecule completed

Quick answer

Alogliptin and metformin for Diabetes Mellitus is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Diabetes Mellitus
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials